Severe mental illnesses (SMIs), including schizophrenia, bipolar disorder and major depressive disorder with psychotic features or severe functional impairment, are chronic psychiatric disorders associated with substantial disability, impaired functioning and premature mortality. Relapse, the recurrence or worsening of psychiatric symptoms after a period of remission, is a common feature of these disorders and contributes to repeated hospitalization, poor functional outcomes and increased healthcare utilization. Despite its clinical and public health importance, evidence on the lifetime occurrence of relapse and its associated factors remains limited in sub-Saharan Africa, particularly in Ethiopia. Therefore, this study aimed to determine the lifetime prevalence of relapse and identify factors associated with relapse among patients with SMI receiving outpatient psychiatric care in Northwest Ethiopia. An institution-based cross-sectional study was conducted among patients with SMI at the University of Gondar Hospital, Northwest Ethiopia, from April 10 to May 24, 2025. A total of 535 patients with SMI were included using systematic random sampling. Lifetime relapse was assessed using a semistructured interviewer-administered questionnaire supported by medical record review. Data on sociodemographic, clinical, treatment-related and psychosocial characteristics were collected. Binary logistic regression analysis was performed to identify factors associated with lifetime relapse. Variables with a p -value <0.20 in the bivariable analysis were entered into the multivariable model, and statistical significance was declared at p < 0.05. The lifetime prevalence of relapse was 61.5% (95% CI: 57.0%–66.0%). In the multivariable binary logistic regression analysis, lifetime relapse was significantly associated with unemployment (adjusted odds ratio [AOR] = 1.65; 95% CI: 1.07–2.55), bipolar disorder (AOR = 3.71; 95% CI: 1.92–7.19), schizophrenia (AOR = 2.73; 95% CI: 1.68–4.46), previous psychiatric hospitalization (AOR = 3.62; 95% CI: 2.26–5.80), two or more prior psychiatric admissions (AOR = 2.32; 95% CI: 1.27–4.23), illness duration of more than 10 years (AOR = 2.04; 95% CI: 1.07–3.88), comorbid medical illness (AOR = 2.41; 95% CI: 1.27–4.58) and experiencing one or two (AOR = 1.81; 95% CI: 1.03–3.18) or three or more stressful life events (AOR = 2.16; 95% CI: 1.16–4.05). Lifetime relapse affected nearly two-thirds of patients with SMI. Factors associated with relapse included unemployment, bipolar disorder, schizophrenia, previous psychiatric hospitalization, multiple prior admissions, longer illness duration, comorbid medical illness and stressful life events. These findings highlight the importance of targeted clinical monitoring and interventions for individuals with characteristics associated with relapse, alongside strengthened continuity of care and integrated mental health services to support relapse prevention and improve long-term outcomes.